Skip to main content
. 2025 Jan 30;26(3):1226. doi: 10.3390/ijms26031226
Akt2 ACT Serine/Threonine Kinase 2
ALA α-linolenic acid
Bc1 complex III or ubiquinol cytochrome C oxidoreductase or cytochrome bc1
Bcl-2 B-cell CLL/lymphoma 2
CDK4 cyclin-dependent kinase 4
CF cystic fibrosis
CGA chlorogenic acid
COX-2 cyclooxygenase 2
CRP C-reactive protein
CVD cardiovascular disease
Cyclo C cytochrome C
DHA docosahexaenoic acid
DSS dextran sodium sulfate
EGFR epidermal growth factor receptor
EL enterolactone
EPA eicosapentaenoic acid
HER2(+) HER2-positive breast cancer
Hs-CRP highly sensitive C-reactive protein
HYA 10-hydroxy-cis-12-octadecenoic acid
IGF-I insulin like growth factor 1
IGFIR insulin like growth factor 1 receptor
IKKβ IκB Kinase β
IL-1β interleukin 1β
IL-6 interleukin 6
IL-10 interleukin 10
LOB3 [1–9-N α C]-linusorb B3
MAPK mitogen-activated protein kinases
MAT matairesinol
NF-κB the nuclear factor kappa B
PGE2 prostaglandin E2
PI3k-Akt the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)
SDG diglucoside secoisolaresinol
SRC proto-oncogene tyrosine-protein kinase Sr
STAT3 signal transducers and activators of transcription 3
sVCAM-1 circulating vascular cell adhesion molecule-1
TNF-α tumor necrosis factor α
TRAS trastuzumab